Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214623 · ClinicalTrials.gov registry record
Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy
A clinical trial, sponsored by Kaneka Medical America.
- Not yet
- Registry status
- 200
- Enrollment target
NCT07214623: Clinical Trial study, sponsored by Kaneka Medical America.
NCT07214623 is a clinical trial that has not yet begun recruiting, run by Kaneka Medical America. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214623 has not yet begun recruiting, sponsored by Kaneka Medical America.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
All participants will be asked to have a minimally invasive procedure for the treatment of chronic subdural hematoma, a blood clot on the brain. Depending on the specific condition patients may also have a surgical procedure, a mini-craniotomy or burr holes where the skull is pierced and the blood clot is drained.
Primary Outcome
Incidence of hematoma recurrence or progression requiring repeat embolization within 180 days
Interventions
- DEVICE Neuro endovascular embolic coil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-11-30 |
| Est. Completion | 2027-05-31 |
What is known before NCT07214623 opens enrollment
NCT07214623 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Neuro endovascular embolic coil is the first listed.
NCT07214623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07214623 about?
NCT07214623 is a clinical study titled "Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy". All participants will be asked to have a minimally invasive procedure for the treatment of chronic subdural hematoma, a blood clot on the brain. Depending on the specific condition patients may also have a surgical procedure, a mini-craniotomy or burr holes where the skull is pierced and the blood c...
What is the current status of trial NCT07214623?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2025-11-30. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT07214623?
The interventions under investigation include: Neuro endovascular embolic coil (DEVICE).
Who is sponsoring clinical trial NCT07214623?
This trial is sponsored by Kaneka Medical America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI